U
nintentional weight loss (i.e., more than a 5% reduction in body weight within six to 12 months) occurs in 15% to 20% of older adults and is associated with increased morbidity and mortality. 1 In this population, unintentional weight loss can lead to functional decline in activities of daily living, 2 increased in-hospital morbidity, 3 increased risk of hip fracture in women, 4 and increased overall mortality. [5] [6] [7] Further, cachexia (loss of muscle mass with or without loss of fat) has been associated with negative effects such as increased infections, pressure ulcers, and failure to respond to medical treatments. 1 Because unintentional weight loss is a nonspecific condition and no published guidelines exist for evaluation and management, the appropriate workup, if any, is difficult to determine. This article focuses on the evaluation, diagnosis, and potential treatments of unintentional weight loss in patients older than 65 years.
Etiology
The pathophysiology of unintentional weight loss is poorly understood. Multiple studies have looked at inflammatory cytokines such as tumor necrosis factor α, interleukin-1β, and interleukin-6, and gut hormones such as cholecystokinin, glucagon-like peptide, and ghrelin. 8 Elevated concentrations of tumor necrosis factor α have been associated with weight loss. It is unclear whether this relationship is a direct cause or a marker for an underlying condition. 9 Body composition changes with age. Lean body mass begins to decrease up to 0.7 lb (0.3 kg) per year in the third decade. This loss is offset by gains in fat mass that continue until 65 to 70 years of age. Total body weight usually peaks at 60 years of age with small decreases of 0.2 to 0.4 lb (0.1 to 0.2 kg) per year after 70 years of age. Therefore, substantial weight changes should not be attributed to normal anorexia of aging. 10 In community-dwelling older adults, the causes of unintentional weight loss can be classified as organic or psychosocial. Multiple studies, prospective and retrospective and in inpatient and outpatient settings, have demonstrated that the most common etiologies are malignancy (19% to 36%), nonmalignant gastrointestinal disease (9% to 19%), and psychiatric conditions such as depression and dementia (9% to 24%). Overall, nonmalignant diseases are more common than malignancy. 1, [11] [12] [13] [14] [15] [16] Etiologies are further delineated in Table 1 . [11] [12] [13] [14] [15] [16] Medication adverse effects (Table 2 1,17,18 ) are common but often overlooked causative factors. 17 Polypharmacy has been shown to interfere with taste and can cause anorexia. 19 In addition, a variety of social factors are associated with unintentional weight loss and include poverty, alcoholism, isolation, financial constraints, and other barriers to obtaining food (e.g., impairment in activities of daily living, lack of assistance in grocery shopping or preparing meals).
1 In 16% to 28% of patients, no readily identifiable cause for unintentional weight loss is determined. [11] [12] [13] [14] [15] [16] Several tools have been developed to aid physicians in remembering the multiple etiologies of unintentional weight loss. These include the mnemonic Meals on Wheels (medication effects; emotional problems, especially depression; anorexia nervosa; alcoholism; late-life paranoia; swallowing disorders; oral factors, such as poorly fitting dentures and caries; no money; wandering and other dementiarelated behaviors; hyperthyroidism, hypothyroidism, hyperparathyroidism, and hypoadrenalism; enteric problems; eating problems, such as inability to feed oneself; low-salt and low-cholesterol diet; stones; social problems, such as isolation and inability to obtain preferred foods). 20 Another tool is the 9 D's of weight loss in the elderly (dementia, dentition, depression, diarrhea, disease [acute and chronic], drugs, dysfunction [functional disability], dysgeusia, dysphagia).
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History and Physical Examination
The evaluation of unintentional weight loss starts with a patient history. If there is a concern about cognitive impairment, a caregiver or family member can provide corroborating information. The history should focus on the amount of weight lost and the time frame in which the weight loss
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Unintentional weight loss of more than 5% within six to 12 months is associated with increased morbidity and mortality in older adults and should prompt evaluation. occurred. If no baseline weight is available, evidence of change in clothing size, confirmation of weight loss by a relative or friend, and a numerical estimate of weight loss can be used. [11] [12] [13] [14] [15] [16] Assessing appetite determines if the weight loss is related to poor food intake. A review of systems to detect acute illness or worsening chronic conditions is important and should pay particular attention to cardiovascular, respiratory, and gastrointestinal symptoms ( Table 3) .
The history should also identify prescription and over-the-counter medications and herbal supplements that may be affecting appetite or contributing to weight loss. A social history focusing on alcohol and tobacco use and the patient's living situation may elicit further useful information. The Mini Nutritional Assessment is a validated tool to help measure nutritional risk. 22 The tool, which is available at http://www. mna-elderly.com /mna _forms.html, involves anthropometric measurements and general, dietary, and subjective assessments. Scoring allows categorization of older adults as well nourished (normal), at risk, or malnourished. 22 The Nutritional Health Checklist (Table 4 ) is a simpler tool for assessing nutritional status that was developed for the Nutrition Screening Initiative. 23 Assessment for depression and dementia is also vital because both have been shown to contribute to unintentional weight loss in older adults. 1 The physical examination can aid in evaluating concerns prompted by history findings. Body weight without shoes should be assessed on a clinic scale. Evaluation of the oral cavity and dentition may indicate difficulty with chewing or swallowing. Heart, lung, gastrointestinal, and neurologic examinations evaluate for illnesses contributing to or causing weight loss.
Diagnostic Studies
Baseline investigations include laboratory studies and imaging. Recommended laboratory tests include complete blood count, basic metabolic panel, liver function tests, thyroid function tests, C-reactive protein levels, erythrocyte sedimentation rate, glucose measurement, lactate dehydrogenase measurement, and urinalysis.
1 Chest radiography and fecal occult blood testing should also be performed. Abdominal ultrasonography may be considered. 1 A prospective study evaluated 101 patients (inpatient and outpatient) with an average age of 64 years and unintentional weight loss of at least 5% within six to 12 months. 12 Baseline evaluation included a comprehensive history and physical examination, the laboratory studies mentioned in the previous paragraph except for fecal occult blood testing, and abdominal ultrasonography and ferritin measurement. After baseline evaluation, the etiology of unintentional weight loss was established in 73 patients (72%). Organic disease was identified in 57 patients, and 16 patients had a psychiatric diagnosis. More importantly, all of the 22 patients with malignant disease had abnormal results in the baseline assessment. Tests with the highest yield (i.e., typically abnormal in the setting of organic disease) were C-reactive protein, hemoglobin, lactate dehydrogenase, and albumin measurements. None of the 25 patients with negative findings on baseline evaluation had a malignancy on additional workup, such as computed tomography, endoscopy, colonoscopy, magnetic resonance imaging, or radionuclide examinations. Therefore, the authors concluded that if baseline test results are normal, further workup is not necessary, and close observation for three to six months is justified.
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Treatment Treatment should focus on the underlying cause. This often involves a multidisciplinary team, including dentists; dietitians; speech, occupational, or physical therapists; and social service workers. Common strategies to address unintentional weight loss in older adults are dietary changes, environmental modifications, nutritional supplements, flavor enhancers, and appetite stimulants. 27 Diet modification incorporating patient preferences, softer food consistency to accommodate for chewing or swallowing disabilities, and assisted feeding may lead to weight gain and improved laboratory parameters; however, study results of this approach are mixed. [28] [29] [30] Creating a more leisurely eating environment simulating an in-home dining experience may improve nutrition in nursing home residents. 31 Nutritional supplements are predominantly available in liquid form, but also come in puddings, bars, and soups. Nutritional supplements should provide extra calories but not replace scheduled meals. Liquid oral supplements allow for rapid gastric emptying and can be given two hours before a meal. 29 Flavor enhancers such as ham, natural bacon, and roast beef flavors sprinkled on cooked food or added during food preparation may improve food consumption and weight gain, but study results have been mixed. [32] [33] [34] Several medications to stimulate appetite are available, but none have been shown to reduce mortality in older patients with unintentional weight loss. 17, 27 Megestrol (Megace), the most commonly studied medication, has been shown to improve appetite and increase weight gain in patients with cancer and AIDS cachexia 35 ; however, studies in older patients are limited, and there are insufficient data to define an optimal dose. 27, 35 Adverse effects of megestrol include gastrointestinal upset, insomnia, impotence, hypertension, thromboembolic events, and adrenal insufficiency. Therefore, megestrol may not be appropriate for all patients, and the risks vs. benefits and patient preferences should be considered. 18 Mirtazapine (Remeron), a serotonin antagonist used to treat depression, has gained interest as a possible treatment for unintentional weight loss in older patients because 12% of patients who take this drug for depression report weight gain. 36 Although no literature exists to support its use for unintentional weight loss, mirtazapine may be an option for older patients with depression who also have unintentional weight loss. Because dizziness and orthostatic hypotension are possible adverse effects of mirtazapine, caution is warranted in patients at risk of falls. 36, 37 Although cyproheptadine has been studied in patients with cancer and cachexia, 38 routine use in older adults with unintentional weight loss has not been studied. Dronabinol (Marinol) and human growth hormone have been studied in small, limited trials with mixed results for short-term, small weight gains. Dronabinol has been associated with significant adverse effects, particularly central nervous system toxicity. Human growth hormone has been associated with increased mortality.
